Hey! Check this out, a biotech company just poured $200 million into Solana 🧬, and it's not just a "yolo," it's a treasury move that is on fire! Can you imagine companies exchanging greenbacks for crypto? Well, it's happening.
Hold on, this is serious. iSpecimen, a company working with health data, just dropped the bomb: they are going to build a treasury with $200 million in Solana (SOL). Why is this big news? Because it's not just any investor; it's a public biotech company that sees the future in decentralized technology. 🤯
This move is not an isolated case. In 2025, the demand for SOL from companies has multiplied by 20! Yes, you heard right, by twenty. 😱 We went from 173,000 SOL to 3.44 million in the hands of corporations like Upexi and Neptune Digital. Together, these companies already hold $647 million in SOL. What do they hope for? The hope that the price will rise, and on top of that, they can earn an extra 7% with staking, a double play! 🤑
The CEO of iSpecimen made it clear: "We are aligning with the future of decentralized infrastructure and digital assets." And of course, while Bitcoin and Ethereum have always been the kings of corporate treasury, Solana is making strong moves to steal the show.
But be careful, not everything is rosy. After a good surge, the market cooled down in July, with many investors taking profits (over a billion dollars in a single day 🥵), which slightly halted SOL's momentum. However, pro traders are not giving up; buying positions (longs) are coming back strong and are almost reaching 72%. 📈
So, the million-dollar question is: Will this company movement be enough for SOL to break the $180 barrier and soar above $200? Let's see what happens, because the battle for crypto leadership is getting more and more interesting.